HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II - ANVISA Registration 10345162252

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - CLASS II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162252 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, RESPONSE BIOMEDICAL CORP., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162252
Registration Details
ANVISA Registration Number: 10345162252
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família Atellica IM Peptídeo Natriurético tipo B (BNP)
Risk Class II

Registration Details

10345162252

25351728502201704

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 30, 2018

VIGENTE

09/18/2025 19:00:01